Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000244679 | SCV000311161 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000401180 | SCV000373026 | uncertain significance | Glycogen storage disease, type V | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000244679 | SCV000566468 | benign | not specified | 2015-05-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000675639 | SCV000700365 | uncertain significance | not provided | 2017-04-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000401180 | SCV000752189 | benign | Glycogen storage disease, type V | 2024-01-29 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000401180 | SCV004562199 | benign | Glycogen storage disease, type V | 2023-08-08 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000675639 | SCV000801340 | likely benign | not provided | 2017-04-17 | no assertion criteria provided | clinical testing | |
Natera, |
RCV000401180 | SCV001461286 | benign | Glycogen storage disease, type V | 2020-09-16 | no assertion criteria provided | clinical testing |